ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17

Ti, Chaowen; Chen, Huang; Zhou, Wenbo; Bian, Aiwu; Hu, Pan; Miao, Ying; Shao, Ting; Liu, Mingyao; Chen, Yihua*; Yi, Zhengfang*
International Immunopharmacology2024-1-25DOI: 10.1016/j.intimp.2023.111344
15阅读
引用收藏
分享

摘要

Objectives: Psoriasis is a prevalent chronic inflammatory skin disease in humans that is characterized by frequent relapses and challenging to cure. WB518 is a novel small molecule compound with an undisclosed structure. Therefore, our study aimed to investigate the therapeutic potential of WB518 in vitro and in vivo for the treatment of psoriasis, specifically targeting the abnormal proliferation, aberrant differentiation of epidermal keratinocytes, and pathogenic inflammatory response. Materials and Methods: We employed dual luciferase reporter assay to screen compounds capable of inhibiting STAT3 gene transcription. Flow cytometry was utilized to analyze CD3-positive cells. Protein and mRNA levels were assessed through Western blotting, immunofluorescence, immunohistochemistry, and real-time PCR. Cell viability was measured using the MTS assay, while in vivo models of psoriasis induced by IMQ and TPA were employed to study the anti-psoriasis effect of WB518. Results: WB518 was found to significantly reduce the mRNA and protein levels of Keratin 17 (K17) in HaCaT cells by inhibiting the phosphorylation of STAT3 Tyr705 (Y705). In the IMQ and TPA-induced psoriasis mouse model, WB518 effectively improved scaling, epidermal hyperplasia, and inflammation. WB518 also suppressed the expression of inflammatory cytokines, such as interleukin (IL)-1 beta, IL-6, IL-17, and IL-23. Furthermore, WB518 decreased the proportion of CD3-positive cells in the psoriatic skin of mice. Conclusions: WB518 exhibits promising potential as a treatment candidate for psoriasis.

学科与关键词

关键词
STAT3Keratin 17PsoriasisSmall molecule inhibitor
相关
加载中…
  • Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation
    Zhou, Jing; Bian, Huiying; Wu, Nan*JOURNAL OF DERMATOLOGY, 2023, 50(10): 1262-1271.
  • Apigenin ameliorates imiquimod-induced psoriasis in C57BL/6J mice by inactivating STAT3 and NF-KB
    Meng, Xianshe; Zheng, Shihong; Yin, Zequn; Wang, Xuerui; Yang, Daigang; Zou, Tingfeng; Li, Huaxin; Chen, Yuanli; Liao, Chenzhong*; Xie, Zhouling; Fan, Xiaodong; Han, Jihong; Duan, Yajun*; Yang, Xiaoxiao*Food Science and Human Wellness, 2024, 13(1): 211-224.被引 1
  • Extracts from Seseli mairei Wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells
    Wang, Mengmeng; Yin, Xunqing; Zeng, Yongcheng; Hu, Chunyan; Xue, Yongmei; Fang, Qionglian; Qiao, Xue; Zhao, Xiujuan; Du, Chenghong; Huang, Feng*; Lin, Yuping*Heliyon, 2023, 9(7): e17315.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2024-01-25
卷期
第 127 卷
页码
111344
DOI
10.1016/j.intimp.2023.111344
语言
ENGLISH
成果收录
SCIE

作者

  • T

    Ti, Chaowen (第一作者)

  • C

    Chen, Huang

查看全部 10 位作者收起作者
  • Z

    Zhou, Wenbo

  • B

    Bian, Aiwu

  • H

    Hu, Pan

  • M

    Miao, Ying

  • S

    Shao, Ting

  • L

    Liu, Mingyao

  • C

    Chen, Yihua (通讯)

  • Y

    Yi, Zhengfang (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417